Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, July 2013

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Unravelling the complexity of kidney renal clear cell carcinoma prognosis: integrating chromatin regulators, gene signatures and associated immune landscapes

Preprint in Research Square (November 2023)

Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma

Article in European Urology Oncology (February 2023)

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma

Article in Frontiers in Public Health (April 2022)